Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis

Nature Neuroscience

Volumn 7, Issue 9, 2004, Pages 954-960

  Herzig, Martin C ^a,b   Winkler, David T ^b   Burgermeister, Patrick ^b   Pfeifer, Michelle ^a,b   Kohler, Esther ^a,b   Schmidt, Stephen D ^c   Danner, Simone ^d   Abramowski, Dorothee ^d   Stürchler Pierrat, Christine ^d   Bürki, Kurt ^e   Van Duinen, Sjoerd G ^f   Maat Schieman, Marion L C ^f   Staufenbiel, Matthias ^d   Mathews, Paul M ^c   Jucker, Mathias ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

^e UNIVERSITY OF ZURICH   (Switzerland)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA-PROTEIN (1-42); GLUTAMIC ACID; GLUTAMINE; PEPTIDE FRAGMENT; THY 1 ANTIGEN;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; DEMENTIA; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; INFLAMMATION; MOUSE; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; SMOOTH MUSCLE; STROKE; TRANSGENIC MOUSE; VASCULAR AMYLOIDOSIS; AGE; AGED; ANIMAL; BLOOD VESSEL; BRAIN; BRAIN CIRCULATION; C57BL MOUSE; CADAVER; COMPARATIVE STUDY; DISEASE MODEL; ELECTRON MICROSCOPY; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METABOLISM; METHODOLOGY; MIDDLE AGED; MUTATION; PATHOLOGY; PIA MATER; ULTRASTRUCTURE; WESTERN BLOTTING;

AGE FACTORS; AGED; AGED, 80 AND OVER; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOIDOSIS; ANIMALS; ANTIGENS, THY-1; BLOOD VESSELS; BLOTTING, WESTERN; BRAIN; CEREBRAL HEMORRHAGE; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; ENCEPHALITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUTAMIC ACID; GLUTAMINE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, ELECTRON; MIDDLE AGED; MUTATION; PEPTIDE FRAGMENTS; PIA MATER; POSTMORTEM CHANGES;

EID: 4344648449     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn1302     Document Type: Article

References (50)

1. Haass, C. & Steiner, H. Protofibrils, the unifying toxic molecule of neurodegenerative disorders? Nat. Neurosci. 4, 859-860 (2001).
2. Hardy, J. Amyloid, the presenilins and Alzheimer's disease. Trends. Neurosci. 20, 154-159 (1997).
3. Selkoe, D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399, A23-31 (1999).
4. Levy, E. et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248, 1124-1126 (1990).
5. Wattendorff, A.R., Bots, G.T., Went, L.N. & Endtz, L.J. Familial cerebral amyloid angiopathy presenting as recurrent cerebral haemorrhage. J. Neurol. Sci. 55, 121-135 (1982).
6. Bornebroek, M., Haan, J., Maat-Schieman, M.L., Van Duinen, S.G. & Roos, R.A. Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D). I. A review of clinical, radiologic and genetic aspects. Brain. Pathol. 6, 111-114 (1996).
7. Maat-Schieman, M.L., van Duinen, S.G., Bornebroek, M., Haan, J. & Roos, R.A. Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D). II. A review of histopathological aspects. Brain. Pathol. 6, 115-120 (1996).
8. Vinters, H.V. Cerebral amyloid angiopathy. A critical review. Stroke 18, 311-324 (1987).
9. Greenberg, S.M. Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment. Neurology 51, 690-694 (1998).
10. Fraser, P.E. et al. Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid β-protein. Biochemistry 31, 10716-10723 (1992).
11. De Jonghe, C. et al. Flemish and Dutch mutations in amyloid β precursor protein have different effects on amyloid β secretion. Neurobiol. Dis. 5, 281-286 (1998).
12. Watson, D.J., Selkoe, D.J. & Teplow, D.B. Effects of the amyloid precursor protein Glu693ÆGln 'Dutch' mutation on the production and stability of amyloid β-protein. Biochem. J. 340 (Pt 3), 703-709 (1999).
13. Monro, O.R. et al. Substitution at codon 22 reduces clearance of Alzheimer's amyloid-β pelptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood. Neurobiol. Aging 23, 405-412 (2002).
14. Van Nostrand, W.E., Melchor, J.P. & Ruffini, L. Pathologic amyloid β-protein cell surface fibril assembly on cultured human cerebrovascular smooth muscle cells. J. Neurochem. 70, 216-223 (1998).
15. Klafki, H.W., Wiltfang, J. & Staufenbiel, M. Electrophoretic separation of βA4 peptides (1-40) and (1-42). Anal. Biochem. 237, 24-29 (1996).
16. Citron, M. et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nat. Med. 3, 67-72 (1997).
17. De Jonghe, C. et al. Evidence that Aβ42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype. Neurobiol. Dis. 6, 280-287 (1999).
18. Castano, E.M. et al. The length of amyloid-β in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-β 1-42 in Alzheimer's disease. J. Biol. Chem. 271, 32185-32191 (1996).
19. Prelli, F. et al. Expression of a normal and variant Alzheimer's β-protein gene in amyloid of hereditary cerebral hemorrhage, Dutch type: DNA and protein diagnostic assays. Biochem. Biophys. Res. Commun. 170, 301-307 (1990).
20. Jankowsky, J.L. et al. Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase. Hum. Mol. Genet. 13, 159-170 (2004).
21. Johnson-Wood, K. et al. Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl. Acad. Sci. USA 94, 1550-1555 (1997).
22. Richards, J.G. et al. PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation. J. Neurosci. 23, 8989-9003 (2003).
23. Hsiao, K. et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-102 (1996).
24. Nilsberth, C. et al. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation. Nat. Neurosci. 4, 887-893 (2001).
25. Tsubuki, S., Takaki, Y. & Saido, T.C. Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Aβ to physiologically relevant proteolytic degradation. Lancet 361, 1957-1958 (2003).
26. Morelli, L. et al, Differential degradation of amyloid β genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme. J. Biol. Chem. 278, 23221-23226 (2003).
27. Borchelt, D.R. et al. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19, 939-945 (1997).
28. Holcomb, L. et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4, 97-100 (1998).
29. Natte, R. et al. Ultrastructural evidence of early non-fibrillar Aβ42 in the capillary basement membrane of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type. Acta Neuropathol. (Berl.) 98, 577-582 (1999).
30. Meyer-Luehmann, M. et al. Extracellular amyloid formation and associated pathology in neural grafts. Nat. Neurosci. 6, 370-377 (2003).
31. Shibata, M. et al. Clearance of Alzheimer's amyloid-β(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 106, 1489-1499 (2000).
32. Weller, R.O. et al. Cerebral amyloid angiopathy amyloid β accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am. J. Pathol. 153, 725-733 (1998).
33. Pfeifer, M. et al. Cerebral hemorrhage after passive anti-Aβ immunotherapy. Science 298, 1379 (2002).
34. Das, P., Murphy, M.P., Younkin, L.H., Younkin, S.G. & Golde, T.E. Reduced effectiveness of Aβ1-42 immunization in APP transgenic mice with significant amyloid deposition. Neurobiol. Aging 22, 721-727 (2001).
35. Nicoll, J.A. et al. Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report. Nat. Med. 9, 448-452 (2003).
36. Koller, M.F. et al. Active immunization of mice with an Aβ-Hsp70 vaccine. Neurodegenerative Dis. 1, 20-28 (2004).
37. Ferrer, I., Boada Rovira, M., Sánchez Guerra, M.L., Rey, M.J. & Costa-Jussá, F. Neuropathology and pathogenesis of encephalitis following amyloid-β immunization in Alzheimer's disease. Brain Pathol. 14, 11-20 (2004).
38. Natte, R. et al. Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann. Neurol. 50, 765-772 (2001).
39. Greenberg, S.M. Cerebral amyloid angiopathy and dementia: two amyloids are worse than one. Neurology 58, 1587-1588 (2002).
40. Christie, R., Yamada, M., Moskowitz, M. & Hyman, B. Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy. Am. J. Pathol. 158, 1065-1071 (2001).
41. Winkler, D.T. et al. Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. J. Neurosci. 21, 1619-1627 (2001).
42. Calhoun, M.E. et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc. Natl. Acad. Sci. USA 96, 14088-14093 (1999).
43. Van Dorpe, J. et al. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons. Am. J. Pathol. 157, 1283-1298 (2000).
44. Sturchler-Pierrat, C. et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA 94, 13287-13292 (1997).
45. Bodendorf, U. et al. Expression of human β-secretase in the mouse brain increases the steady-state level of β-amyloid. J. Neurochem. 80, 799-806 (2002).
46. Mehta, P.D. et al. Plasma and cerebrospinal fluid levels of amyloid β proteins 1-40 and 1-42 in Alzheimer disease. Arch. Neurol. 57, 100-105 (2000).
47. Ohsawa, K., Imai, Y., Kanazawa, H., Sasaki, Y. & Kohsaka, S. Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia. J. Cell. Sci. 113 (Pt 17), 3073-3084 (2000).
48. Janus, C. et al. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408, 979-982 (2000).
49. Rozmahel, R. et al. Normal brain development in PSI hypomorphic mice with markedly reduced γ-secretase cleavage of βAPP. Neurobiol. Aging 23, 187-194 (2002).
50. Maat-Schieman, M.L., Yamaguchi, H., van Duinen, S.G., Natte, R. & Roos, R.A. Age-related plaque morphology and C-terminal heterogeneity of amyloid β in Dutch-type hereditary cerebral hemorrhage with amyloidosis. Acta Neuropathol. (Berl.) 99, 409-419 (2000).